Financial reports
10-Q
2022 Q2
Quarterly report
9 Aug 22
10-Q
2022 Q1
Quarterly report
5 May 22
10-K
2021 FY
Annual report
24 Feb 22
10-Q
2021 Q3
Quarterly report
8 Nov 21
10-Q
2021 Q2
Quarterly report
5 Aug 21
10-Q
2021 Q1
Quarterly report
7 May 21
10-K
2020 FY
Annual report
25 Feb 21
10-Q
2020 Q3
Quarterly report
5 Nov 20
10-Q
2020 Q2
Quarterly report
10 Aug 20
Current reports
8-K
Entry into a Material Definitive Agreement
15 Aug 22
8-K
Entry into a Material Definitive Agreement
2 Aug 22
8-K
Submission of Matters to a Vote of Security Holders
28 Jul 22
8-K
Other Events
27 Jun 22
8-K
Radius Health Announces Agreement to be Acquired by
23 Jun 22
8-K
Menarini Group and Radius Health Submit New Drug Application to the U.S. FDA for Elacestrant
22 Jun 22
8-K
Termination of a Material Definitive Agreement
8 Jun 22
8-K
Regulation FD Disclosure
6 Jun 22
8-K
Radius Adds Industry Veterans Jennifer A. Jarrett and Susan Vissers Lisa to Board of Directors
20 May 22
8-K
First Quarter 2022 Results
5 May 22
Registration and prospectus
15-12G
Securities registration termination
25 Aug 22
S-8 POS
Registration of securities for employees (post-effective amendment)
15 Aug 22
S-8 POS
Registration of securities for employees (post-effective amendment)
15 Aug 22
S-8 POS
Registration of securities for employees (post-effective amendment)
15 Aug 22
S-8 POS
Registration of securities for employees (post-effective amendment)
15 Aug 22
S-8 POS
Registration of securities for employees (post-effective amendment)
15 Aug 22
S-8 POS
Registration of securities for employees (post-effective amendment)
15 Aug 22
S-8 POS
Registration of securities for employees (post-effective amendment)
15 Aug 22
S-8 POS
Registration of securities for employees (post-effective amendment)
15 Aug 22
S-8 POS
Registration of securities for employees (post-effective amendment)
15 Aug 22
Proxies
DFAN14A
Additional proxy materials by non-management
11 Jul 22
DEFA14A
Additional proxy soliciting materials
7 Jul 22
DEFA14A
Additional proxy soliciting materials
7 Jul 22
DEFA14A
Additional proxy soliciting materials
27 Jun 22
DFAN14A
Additional proxy materials by non-management
24 Jun 22
DFAN14A
Additional proxy materials by non-management
21 Jun 22
DFAN14A
Additional proxy materials by non-management
17 Jun 22
DFAN14A
Additional proxy materials by non-management
13 Jun 22
DFAN14A
Additional proxy materials by non-management
7 Jun 22
DEFC14A
Proxy in contested solicitation
6 Jun 22
Other
UPLOAD
Letter from SEC
14 Jul 22
UPLOAD
Letter from SEC
10 Jan 22
CORRESP
Correspondence with SEC
7 Jan 22
UPLOAD
Letter from SEC
29 Dec 21
SEC STAFF
SEC staff action: Order
10 Mar 21
SEC STAFF
SEC staff action: Order
9 Feb 21
CT ORDER
Confidential treatment order
20 May 20
CT ORDER
Confidential treatment order
23 Aug 18
CT ORDER
Confidential treatment order
14 Jun 18
UPLOAD
Letter from SEC
31 Jan 18
Ownership
SC 13D/A
BB BIOTECH AG
30 Aug 22
4
BIOTECH AG BB
30 Aug 22
SC 13D/A
Velan Capital Investment Management LP
26 Aug 22
SC 13G
ICS OPPORTUNITIES II LLC
17 Aug 22
4
Susan Vissers Lisa
15 Aug 22
4
MACHELLE SANDERS
15 Aug 22
4
Owen Hughes
15 Aug 22
4
Chhaya Shah
15 Aug 22
4
CATHY FRIEDMAN
15 Aug 22
4
Willard H Dere
15 Aug 22